BMO Capital raised the firm’s price target on WM (WM) to $234 from $232 and keeps a Market Perform rating on the shares. The outsized ...

BMO Capital raised the firm’s price target on Visa (V) to $370 from $350 and keeps an Outperform rating on the shares. The company saw ...

SAP (NYSE:SAP – Get Free Report) had its price objective boosted by equities research analysts at BMO Capital Markets from $265.00 to $307.00 in a research report issued on Wednesday,Benzinga reports.

BMO Capital Markets increased its price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares, moving the goalpost from $520 to $545 while maintaining an Outperform rating. Currently ...

Fintel reports that on January 30, 2025, BMO Capital downgraded their outlook for Everest Group (NYSE:EG) from Outperform to Market Perform. Analyst Price Forecast Suggests 22.68% Upside As of January ...

Geneos Wealth Management Inc. bought a new stake in shares of Bank of Montreal (NYSE:BMO – Free Report) (TSE:BMO) in the 4th ...

Inflation adjusted cobalt prices are the lowest in 100 years after a deluge of new supply. Stagnating demand from EVs only adds to the bear case.

The acquisition of Chemelex, a manufacturer of electric heat tracing systems, was completed with an equity investment share of $210 million. Management cited this as an example of leveraging ...

In this article, we will discuss the 12 Best Chemical Stocks to Buy According to Analysts.

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.